Manchester Capital Management’s Outset Medical OM Stock Holding History

Manchester Capital Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$131	–	1057
2023 Q3	$131	Sell	1 -8	-89%	-$1.89K	﹤0.01%	981
2023 Q2	$2.93K	Hold	9	–	–	﹤0.01%	685
2023 Q1	$2.47K	Buy	9 +1	+13%	+$367	﹤0.01%	755
2022 Q4	$2.94K	Sell	8 -1	-11%	-$282	﹤0.01%	625
2022 Q3	$2K	Sell	9 -4	-31%	-$1.07K	﹤0.01%	675
2022 Q2	$3K	Buy	+13	New	+$5.59K	﹤0.01%	639

Other funds holding OM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Manchester Capital Management's OM Position: Q4 2023 in Review

Manchester Capital Management sold out of Outset Medical (OM) in Q4 2023, closing a stake of 1 share — an estimated $131 sold.

Manchester Capital Management first reported a position in OM in Q2 2022 and held it in 6 quarters. The position peaked at $3K in Q2 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

Manchester Capital Management reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
Manchester Capital Management sold 1 Outset Medical share in Q4 2023, an estimated $131.
Manchester Capital Management first reported a position in Outset Medical in Q2 2022 and held it in 6 quarters.
Manchester Capital Management's Outset Medical position peaked at $3K in Q2 2022.
140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Manchester Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.